Increased gene expression of such molecules as connective tissue growth factor (CTGF), vascular endothelial growth factor (VEGF), bone morphogenetic proteins (BMPs) and gremlin, a BMP antagonist, supports the notion that ontogenic processes are operative in the development of DN[6], [8], [9], [10]. The gene discussed is GREM1; the disease is liver dysplastic nodule.